This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
User:Tilman Schirmer/Sandbox 201
From Proteopedia
(Difference between revisions)
(→Primary and secondary inhibition sites) |
|||
| Line 1: | Line 1: | ||
'''''Diguanylate cyclases''''' | '''''Diguanylate cyclases''''' | ||
| - | == | + | == PleD == |
| - | === | + | === Intro === |
---- | ---- | ||
| - | === | + | === Domain structure === |
| Line 13: | Line 13: | ||
---- | ---- | ||
| - | === | + | === Protomer === |
<applet load='2v0n' scene='User:Tilman_Schirmer/Sandbox_201/Protomer_activeated/1' size='300' frame='true' align='right' caption='2v0n' /> | <applet load='2v0n' scene='User:Tilman_Schirmer/Sandbox_201/Protomer_activeated/1' size='300' frame='true' align='right' caption='2v0n' /> | ||
| Line 22: | Line 22: | ||
---- | ---- | ||
| - | === | + | === Substrate binding site === |
<applet load='2v0n' scene='User:Tilman_Schirmer/Sandbox_201/Substrate_binding_site/2' size='300' frame='true' align='right' caption='2v0n' /> | <applet load='2v0n' scene='User:Tilman_Schirmer/Sandbox_201/Substrate_binding_site/2' size='300' frame='true' align='right' caption='2v0n' /> | ||
| Line 34: | Line 34: | ||
---- | ---- | ||
| - | === | + | === Allosteric product binding site === |
<applet load='2v0n' scene='User:Tilman_Schirmer/Sandbox_201/5gp/1' size='300' frame='true' align='right' caption='Insert caption here' /> | <applet load='2v0n' scene='User:Tilman_Schirmer/Sandbox_201/5gp/1' size='300' frame='true' align='right' caption='Insert caption here' /> | ||
---- | ---- | ||
| Line 68: | Line 68: | ||
---- | ---- | ||
| - | === | + | === Two conformations === |
[[Image:1w25_small.png|frame|left|non-activated (1w25)]] [[Image:2v0n_small_smaller2.png|frame|center|activated (BeF3- modified; 2v0n)]] | [[Image:1w25_small.png|frame|left|non-activated (1w25)]] [[Image:2v0n_small_smaller2.png|frame|center|activated (BeF3- modified; 2v0n)]] | ||
| Line 77: | Line 77: | ||
---- | ---- | ||
| - | === | + | === Non-activated conformation === |
[[1w25]] | [[1w25]] | ||
| Line 93: | Line 93: | ||
---- | ---- | ||
| - | === | + | === Activated conformation === |
[[2v0n]] | [[2v0n]] | ||
| Line 106: | Line 106: | ||
<br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br> | <br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br> | ||
---- | ---- | ||
| - | |||
| - | == 2. WspR == | ||
Revision as of 13:09, 19 June 2009
Diguanylate cyclases
Contents |
PleD
Intro
Domain structure
Protomer
|
: , ,
Substrate binding site
|
Allosteric product binding site
|
C-di-GMP
Primary inhibition site (Ip)
Secondary inhibition site (Is)
Primary and secondary inhibition sites
Two conformations
non-activated (1w25)
activated (BeF3- modified; 2v0n)
|
|
Non-activated conformation
|
: , ,
Activated conformation
|
